BiomX(US:PHGE)2026-03-11 13:02Summary of BiomX Inc. Special Meeting of Stockholders Company Overview - Company: BiomX Inc. (NYSEAM:PHGE) - Date of Meeting: March 11, 2026 - Key Speakers: Michael Oster (CEO), David Rokach (CFO) Key Points Discussed Meeting Structure and Attendance - The meeting was called to order by the CEO, Michael Oster, with the presence of CFO David Rokach, both newly appointed executives [2] - A quorum was established with 556,978 shares represented out of 1,593,516 shares outstanding as of February 3, 2026 [3] Agenda Items 1. Approval of Share Issuance: - The first order of business was to approve the issuance of shares of common stock underlying Series Y convertible preferred stock and warrants [5] - This issuance is in compliance with Section 713(a) of the NYSE American LLC Company Guide and relates to a security purchase agreement dated December 26, 2025, and an engagement letter dated November 26, 2025 [5][6] - The board recommended a vote in favor of this issuance proposal, which requires a majority vote from shareholders present [6] 2. Adjournment Proposal: - The second order of business was to vote on the adjournment of the meeting if necessary to solicit additional proxies for the issuance proposal [7] - This proposal also requires a majority vote from shareholders present, with the board recommending approval [7] Voting Outcomes - Preliminary counts indicated sufficient votes to approve the issuance of shares and to adjourn the meeting if necessary [9] - The issuance of shares was officially declared approved, completing the agenda of the meeting [10] Additional Notes - The meeting included a process for shareholders to vote through a virtual platform, ensuring participation [3][8] - The CEO and CFO expressed their commitment to advancing the company's programs and delivering long-term value to shareholders [2] This summary encapsulates the critical aspects of the special meeting, focusing on the company's governance and shareholder engagement processes.